Epigral Ltd. Cash Flow-to-Debt Ratio
Epigral Ltd. cash flow-to-debt ratio. Epigral Ltd. (EPIGRAL) has a Cash Flow-to-Debt Ratio of 0.24x as of September 2025, meaning its operating cash flow of Rs2.67 Billion could theoretically repay 0% of its total liabilities (Rs11.35 Billion) in one year. Check EPIGRAL capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Epigral Ltd. (2015–2026)
Cash flow-to-debt ratio of Epigral Ltd. from 2015 to 2026. Historical debt coverage capacity for Epigral Ltd. across 12 annual periods. Check Epigral Ltd. cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Epigral Ltd. Cash Flow-to-Debt Ratio by Year (2015–2026)
Epigral Ltd. cash flow-to-debt ratio by year from 2015 to 2026. Year-by-year debt coverage analysis for Epigral Ltd.. For the full cash flow conversion analysis, see cash efficiency ratio of Epigral Ltd..
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | 0.30x | Rs3.88 Billion | Rs12.84 Billion | ▼ -14.5% |
| 2025 | 0.35x | Rs4.41 Billion | Rs12.48 Billion | ▲ +36.7% |
| 2024 | 0.26x | Rs3.98 Billion | Rs15.40 Billion | ▼ -43.8% |
| 2023 | 0.46x | Rs6.26 Billion | Rs13.63 Billion | ▲ +126.2% |
| 2022 | 0.20x | Rs2.84 Billion | Rs13.98 Billion | ▼ -32.3% |
| 2021 | 0.30x | Rs2.29 Billion | Rs7.65 Billion | ▲ +25.6% |
| 2020 | 0.24x | Rs1.65 Billion | Rs6.90 Billion | ▼ -49.6% |
| 2019 | 0.47x | Rs2.61 Billion | Rs5.51 Billion | ▼ -67.6% |
| 2018 | 1.46x | Rs2.25 Billion | Rs1.54 Billion | ▲ +75.5% |
| 2017 | 0.83x | Rs1.38 Billion | Rs1.66 Billion | ▲ +65.6% |
| 2016 | 0.50x | Rs1.23 Billion | Rs2.45 Billion | ▲ +41.1% |
| 2015 | 0.36x | Rs1.12 Billion | Rs3.14 Billion | — |